Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Cagrilintide for Sale > 99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - large image1
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - image1
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - image2
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - image3
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - image4
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - image5
99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack buy - image6

99% purity cagrilintide 5mg+Samaglutide 5mg high quality 10mg/vial Jack

66 Inquiries

Unit Price:

$5/UNIT FOB

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical

Content:

99%

Port:

Hong Kong

Brand:

HUATAI

Packaging:

10vials

Price valid (until):

2026-11-08

Company Type:
Trader
Location:
China
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail   


    Contact us  

    whatsapp: 

    +852 4707 2490 Jack 

    Cagrilintide 5mg+Samaglutide 5mg is a synthetically produced, highly active peptide/bioactive molecule. It’s manufactured using advanced solid-phase synthesis techniques, resulting in a purity of ≥99%. The product exhibits batch stability, high activity, and well-controlled impurities. As a research-grade reagent, it’s ideal for cell experiments, mechanism studies, pharmacological research, and formula development. It provides high-quality materials for research in related fields.

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide

    Location:

    1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province

    Payment Terms:

    TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1 days

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Company Certificates
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA
    • HUATAI PEPTIDESCOA COA

    COMPANY INTRODUCTION

    20 years of dedicated work in the peptide industry

    15 Years of Industry Experience

    We have been a high-tech company focused on the development, production, and marketing of various peptide products

     for 15 years. Through advanced laboratories and strict quality control, our internationally certified products are safe and 

    effective.


    Clients in Europe, the USA, Southeast Asia, and the Middle East

    As a global trading company, we serve clients across Europe, the USA, Southeast Asia, the Middle East, and beyond, providing

     customized solutions. Committed to "technology leading Health", we aim to innovate and deliver high-quality health products 

    worldwide.


    3,000sqm Factory with 60 Employees

    We have a factory covering 3,000 square meters and housing 60 employees to guarantee the highest quality all the time. We hired 

    three quality auditors with three years of experience. They meticulously inspect each item at every production stage.


    Contact Us Now

    Our products are exported to more than 130 countries and regions, which can be delivered fast within 5-14 days. We can provide

     OEM/ODM support to our customers. We have 10 professional after-sales staff to make 24-hour responses to our customers. 

    Contact us now to learn more. We hope to establish stable and strategic long-term business relationships with domestic and 

    foreign suppliers and customers, jointly pursuing a better future.


  • Inquiry History
    66 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    10 MG Sep 23, 2026
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    United Kingdom

    CAGRILLINTED

    10  May 3, 2026
    Hongkong, China

    Cagrilintide

    100 MG Apr 22, 2026
    United Kingdom

    Cagrilintide

    1 KG Apr 14, 2026
    Ireland

    Cagrilintide

    10 PCS Apr 14, 2026
    United States

    Cargrilintide

    10 MG Mar 19, 2026
    United Kingdom

    cagrilintide

    10 MG Feb 18, 2026
    China

    CagriSema cagrilintide 2.5mg+Samaglutide2.5mg

    10 MG Jan 26, 2026
    South Korea

    Cagrilintide

    500 MG Jan 21, 2026
    Pakistan

    cagrilintide

    1 KG Dec 26, 2025
    United States

    Cagrilintide

    20 MG Dec 19, 2025
    United Kingdom

    Cagrilintide

    100 MG Dec 10, 2025
    Canada

    All peptides

    1001 MT Nov 12, 2025
    United States

    Cagrilintide

    10 MG Oct 13, 2024
    United States

    Cagrilintide

    1 MG Jun 3, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.